New Delhi [India], April 19 (ANI/SRV): Aaquaries Global Industries Limited, Mumbai based top research-driven pharmaceutical company started in the year 2007 focusing on contract manufacturing APIs from Natural Extracts for Malaria Anti - Cancer & various other segments & a leading exporter of Oncology & Malarial APIs from natural sources with patents filed for Non- Infringing ROS. Manufacturing Facilities are EUGMP / USFDA compliant received the most prestigious & coveted "Innovative R&D Company of the Year 2023" at the ASSOCHAM's national seminar organized under the theme Healthcare 5.0: Enhancing Healthcare Capabilities and Leadership Excellence Awards on 19th April 2023 at Kolkata. Dr Sameer Talim, Managing Director, Aaquaries Global Industries Limited & Dr Susmita Nayak, Director, Research & Development received the coveted trophy & certificate of excellence from received the coveted trophy & certificate of excellence from His Excellency Peter Cook, Deputy High Commissioner, British Deputy High Commission, Ahmedabad, & Kolkata in a power-packed gathering of industry leaders, renowned doctors, policymakers & bureaucrats. Y Ratnakar Rao, I.A.S., Secretary, Dept. of Health and Family Welfare, Govt. of West Bengal, Dr Ajay Swaroop, Chairman, Sir Gangaram Hospital. New Delhi, ASSOCHAM National Healthcare Committee Member, Dr Rupali Basu, MD & CEO, Woodlands Multispeciality Hospital Ltd., Harshvardhan Neotia, Chairman, Ambuja Neotia Group, Narayan Swarup Nigam, I.A.S., Principal Secretary, Health and Family Welfare Department, Govt. of West Bengal were some of the dignitaries present in the August gatherings. Speaking on this, Dr Sameer Talim, Managing Director, Aaquaries Global Industries Limited said "We are humbled & excited to receive this recognition. Aaquaries Global has been at the forefront of R & D innovations. The R&D team at Aaquaries Global Industries is relentlessly working towards developing indigenous diagnostic solutions to combat the raging disease. Aaquaries Global's Research & Development (R & D) team is the foundation of our innovative product pipeline. The Government of India has recently introduced several steps for the advancement of R&D in the pharma sector, including the Umbrella Scheme of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India (DoP) namely 'Scheme for Development of Pharmaceutical Industry'. This initiative aims to boost the effectiveness and competitiveness of the domestic pharmaceutical industry to help India's position in the global market and ensure accessibility. The DoP also recently unveiled a Draft Policy to catalyse R&D and innovation in the pharma-medtech Sector with the aim of enabling an accommodating regulatory environment to speed up R&D and drive targeted funding, develop strong industry-academia collaboration in accordance with global best practices and create top-class infrastructure for innovation in the pharma-medtech sectors". Dr Susmita Nayak, Director, of Research & Development of Aaquaries Global Industries Limited said "On a global scale, approx. 15 % - 19 % of revenues are spent on R&D and the expenditure is increasing each year. Yet, successful R&D is an elusive area and effort versus success is typically disproportionate. Drug discovery is a risky activity as an average of 5000-10000 lead compounds result in a single successful drug, which can cost in the region of US$ 250-500 million per drug. Aaquaries Global Industries Limited has been extensively using AI in the overall R&D process. We have been constantly upgrading our facility with the latest infrastructure & equipment to further our quest in the areas of NDDS, and NCE's". Aaquaries Global Industries Limited, headquartered in Mumbai, India is one of the fastest-growing pharmaceutical companies focusing on the development, manufacturing, and sale of high-quality and affordable process R&D and API manufacturing service providers for the worldwide pharmaceutical industry since 2007. Aaquaries Global Industries Limited has uniquely integrated development, regulatory, and manufacturing capabilities & has offices in Dubai, Singapore, and Hong Kong. Aaquaries Global Industries Limited offers a wide portfolio of services ranging from APIs for the generic industry to custom synthesis for early-phase pharmaceutical research and branded products. Aaquaries Global Industries Limited is a customer-focused backward-integrated world-class developer, manufacturer & trading of Active Pharmaceutical Ingredients (APIs). It is the independent company of choice in collaboration with leading producers of advanced API solutions with state of manufacturing facilities with stringent operating procedures and compliance to current Good Manufacturing Practices (cGMP) and applicable regulatory requirements and reliable supply to gain a sustainable competitive advantage. Aaquaries Global Industries has a wide basket of a portfolio that includes over 300 APIs across multiple therapeutic segments with a marketing presence in over 75 countries in the Middle East, European and African countries. This story has been provided by SRV. ANI will not be responsible in any way for the content of this article. (ANI/SRV)
Related Keywords
Kolkata , West Bengal , India , Dubai , Dubayy , United Arab Emirates , Ahmedabad , Gujarat , Singapore , Hong Kong , Mumbai , Maharashtra , United Kingdom , New Delhi , Delhi , British , Rupali Basu , Narayan Swarup Nigam , Susmita Nayak , Harshvardhan Neotia , Peter Cook , Ratnakar Rao , Sameer Talim , Ajay Swaroop , Scheme For Development Of Pharmaceutical Industry , British Deputy High Commission , Innovative Rd Company Of The Year , Family Welfare Department , Aaquaries Global Industries , Ambuja Neotia Group , Aaquaries Global Research Development , Research Development , Woodlands Multispeciality Hospital Ltd , Umbrella Scheme Of The Department Pharmaceuticals , Aaquaries Global Industries Limited Dr Susmita Nayak , Research Development Of Aaquaries Global Industries , Ministry Of Chemicals , National Healthcare Committee Member , Aaquaries Global Industries Limited , Natural Extracts , Malaria Anti , Enhancing Healthcare Capabilities , Leadership Excellence Awards , Managing Director , His Excellency Peter Cook , Deputy High Commissioner , Family Welfare , Sir Gangaram , Healthcare Committee Member , Principal Secretary , Umbrella Scheme , Draft Policy , Global Industries Limited , Active Pharmaceutical Ingredients , Good Manufacturing Practices , Global Industries , Middle East , New Delhi India , Pril 19 Ani Srv Aaquaries Global Industries Limited , Umbai Based Top Research Driven Pharmaceutical Company Started In The Year 2007 Focusing On Contract Manufacturing Apis From Natural Extracts For Malaria Anti Cancer Amp Various Other Segments Ampa Leading Exporter Of Oncology Malarial Sources With Patents Filed Non Infringing Ros Facilities Are Eugmp Usfda Compliant Received Most Prestigious Coveted Quot Innovativer Ampd 2023 At Assocham 39s National Seminar Organized Under Theme Healthcare 5 0 Enhancing Capabilities And Leadership Excellence Awards 19th April Kolkata Dr Sameer Talim , Aquaries Global Industries Limited Amp Dr Susmita Nayak , Director , Esearch Amp Development Received The Coveted Trophy Certificate Of Excellence From His Excellency Peter Cook , Mp Kolkata Ina Power Packed Gathering Of Industry Leaders , Renowned Doctors , Olicymakers Amp Bureaucratsy Ratnakar Rao , Gas , Secretary , Ept Of Health And Family Welfare , Govt Of West Bengal , R Ajay Swaroop , Chairman , Sir Gangaram Hospital New Delhi , Ssocham National Healthcare Committee Member , Dr Rupali Basu , Md Amp Ceo , Oodlands Multispeciality Hospital Ltd , Health And Family Welfare Department , Ovt Of West Bengal Were Some The Dignitaries Present In August Gatherings Speaking On This , R Sameer Talim , Aquaries Global Industries Limited Said Quot We Are Humbled Amp Excited To Receive This Recognition Aaquaries Has Been At The Forefront Ofr Ampd Innovations Ther Team Is Relentlessly Working Towards Developing Indigenous Diagnostic Solutions Combat Raging Disease 39s Research Developmentr Foundation Of Our Innovative Product Pipeline Government India Recently Introduced Several Steps For Advancement In Pharma Sector , Ncluding The Umbrella Scheme Of Department Pharmaceuticals , Ministry Of Chemicals And Fertilizers , Overnment Of India Dop Namely 39 Scheme For Development Pharmaceutical Industry This Initiative Aims To Boost The Effectiveness And Competitiveness Domestic Help 39s Position In Global Market Ensure Accessibility Also Recently Unveileda Draft Policy Catalyser Ampd Innovation Pharma Medtech Sector With Aim Enabling An Accommodating Regulatory Environment Speed Upr Drive Targeted Funding , Evelop Strong Industry Academia Collaboration In Accordance With Global Best Practices And Create Top Class Infrastructure For Innovation The Pharma Medtech Sectors Quot Dr Susmita Nayak , F Research Amp Development Of Aaquaries Global Industries Limited Said Quot Ona Scale , Pprox 15 19 Of Revenues Are Spent Onr Ampd And The Expenditure Is Increasing Each Year Yet , Uccessfulr Ampd Is An Elusive Area And Effort Versus Success Typically Disproportionate Drug Discovery Isa Risky Activity As Average Of 5000 10000 Lead Compounds Result Ina Single Successful , Hich Can Cost In The Region Of Us 250 500 Million Per Drug Aaquaries Global Industries Limited Has Been Extensively Using Ai Overallr Ampd Process We Have Constantly Upgrading Our Facility With Latest Infrastructure Amp Equipment To Further Quest Areas Ndds , Nd Nce 39s Quot Aaquaries Global Industries Limited , Eadquartered In Mumbai , Ndia Is One Of The Fastest Growing Pharmaceutical Companies Focusing On Development , Manufacturing , Nd Sale Of High Quality And Affordable Processr Ampd Api Manufacturing Service Providers For The Worldwide Pharmaceutical Industry Since 2007 Aaquaries Global Industries Limited Has Uniquely Integrated Development , Egulatory , Nd Manufacturing Capabilities Amp Has Offices In Dubai , Nd Hong Kong Aaquaries Global Industries Limited Offersa Wide Portfolio Of Services Ranging From Apis For The Generic Industry To Custom Synthesis Early Phase Pharmaceutical Research And Branded Products Isa Customer Focused Backward Integrated World Class Developer , Anufacturer Amp Trading Of Active Pharmaceutical Ingredients Apis It Is The Independent Company Choice In Collaboration With Leading Producers Advanced Api Solutions State Manufacturing Facilities Stringent Operating Procedures And Compliance To Current Good Practices Cgmp Applicable Regulatory Requirements Reliable Supply Gaina Sustainable Competitive Advantage Aaquaries Global Industries Hasa Wide Basket Ofa Portfolio That Includes Over 300 Across Multiple Therapeutic Segments Witha Marketing Presence 75 Countries Middle East , Uropean And African Countries This Story Has Been Provided By Srv Ani Will Not Be Responsible In Any Way For The Content Of Article ,
comparemela.com © 2020. All Rights Reserved.